LEUKOPENIA
Clinical trials for LEUKOPENIA explained in plain language.
Never miss a new study
Get alerted when new LEUKOPENIA trials appear
Sign up with your email to follow new studies for LEUKOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare immune disorder: drug that mobilizes white blood cells enters trial
Disease control Recruiting nowThis study tests whether Mozobil, a drug already used in stem cell transplants, can safely and effectively raise white blood cell counts in people with WHIMS, a rare genetic condition that causes frequent infections. About 20 adults aged 18 to 75 with WHIMS and a history of sever…
Matched conditions: LEUKOPENIA
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 26, 2026 06:36 UTC
-
Can a drug boost blood cells and delay cancer in people with CCUS?
Disease control Recruiting nowThis study tests the drug luspatercept in 50 adults with clonal cytopenias of uncertain significance (CCUS), a condition where blood cell counts are low and there is a risk of developing blood cancer. Participants receive injections every three weeks for up to 48 weeks. The goal …
Matched conditions: LEUKOPENIA
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 18, 2026 12:13 UTC